✅ #EMPEROR-Pooled trial: a pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
✅ #EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫